Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The update changes the displayed ClinicalTrials.gov page revision number from v3.5.2 to v3.5.3, reflecting a tooling/interface release rather than a modification to the trial record data.
    Difference
    0.1%
    Check dated 2026-04-24T06:44:11.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now listed, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:55:42.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A new version entry was added to the Record History, reflecting updates to the study record such as status, design, eligibility, and contacts/locations.
    Difference
    0.1%
    Check dated 2026-04-09T21:50:31.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision history shows the addition of v3.5.0 and the removal of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:05:15.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Record History shows the addition of Revision: v3.4.3 and the deletion of Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:36:12.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-notice block along with the prior Revision: v3.4.1 entry.
    Difference
    0.8%
    Check dated 2026-02-11T14:18:48.000Z thumbnail image

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.